FDA Approved: SANDIMMUNE — Supplemental Application (Novartis Pharmaceuticals Corporation)

View source ↗

Summary

FDA approved a supplemental application for SANDIMMUNE (cyclosporine) to update and expand its labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Organ Transplantation

Drugs mentioned

• SANDIMMUNE (CYCLOSPORINE)

Snippet

SUPPL AP for SANDIMMUNE (CYCLOSPORINE)